News

Pharmabiz13h
Edwards SAPIEN M3 mitral valve replacement system receives CE Mark for transcatheter treatment
Edwards SAPIEN M3 mitral valve replacement system receives CE Mark for transcatheter treatment: Irvine, California Wednesday, ...
Pharmabiz7h
Exicure’s subsidiary, GPCR Therapeutics doses 19th patient in its phase 2 study of GPC-100 in multiple myeloma
Exicure’s subsidiary, GPCR Therapeutics doses 19th patient in its phase 2 study of GPC-100 in multiple myeloma: Redwood City, California Wednesday, April 16, 2025, 18:00 Hrs [IS ...
Pharmabiz8h
Nexalin Technology receives US patent for Deep Intracranial Frequency Stimulation technology in treating substance use disorders
Nexalin Technology receives US patent for Deep Intracranial Frequency Stimulation technology in treating substance use disorders: Houston, Texas Wednesday, April 16, 2025, 17:00 H ...
Pharmabiz11h
Valneva receives Brazilian marketing authorization for single-dose vaccine Ixchiq for prevention of disease caused by chikungunya virus
Valneva receives Brazilian marketing authorization for single-dose vaccine Ixchiq for prevention of disease caused by chikungunya virus: Saint Herblain, France Wednesday, April 16 ...
Pharmabiz14h
Eisai & Biogen announce update on regulatory review of MAA for lecanemab to treat early Alzheimer’s disease by European Commission
Eisai & Biogen announce update on regulatory review of MAA for lecanemab to treat early Alzheimer’s disease by European Commission: Tokyo Wednesday, April 16, 2025, 11:00 Hrs [I ...
Pharmabiz9h
Dentalkart launches ‘Buying Guide’ to enhance fast purchase of complex dental products
Dentalkart launches ‘Buying Guide’ to enhance fast purchase of complex dental products: Our Bureau, Bengaluru Wednesday, April 16, 2025, 15:30 Hrs [IST] Dentalkart a NSE-liste ...
Pharmabiz9h
US FDA designates Celltrion’s Yuflyma as an interchangeable biosimilar to Humira
US FDA designates Celltrion’s Yuflyma as an interchangeable biosimilar to Humira: Incheon, South Korea Wednesday, April 16, 2025, 16:00 Hrs [IST] Celltrion, Inc. announced that ...
Pharmabiz9h
MediBuddy study shows anxiety affects 32% of young professionals in India
MediBuddy study shows anxiety affects 32% of young professionals in India: Our Bureau, Bengaluru Wednesday, April 16, 2025, 15:15 Hrs [IST] MediBuddy, digital healthcare company, ...
Pharmabiz12h
Pfizer to discontinue development of danuglipron, an oral GLP- receptor agonist for chronic weight management
Pfizer to discontinue development of danuglipron, an oral GLP- receptor agonist for chronic weight management: New York Wednesday, April 16, 2025, 13:00 Hrs [IST] Pfizer Inc. anno ...
Pharmabiz9h
ART Fertility Clinics in collaboration with MOGS host Annual Conference 2025
ART Fertility Clinics in collaboration with MOGS host Annual Conference 2025: Our Bureau, Mumbai Wednesday, April 16, 2025, 15:45 Hrs [IST] ART Fertility Clinics, a global leader ...
Pharmabiz15h
Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD
Sanofi’s respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD: Paris Wednesday, April 16, 2025, 10:00 Hrs [IST] Sanofi shared new pro ...
Pharmabiz17h
CDSCO asks States and UTs to act upon list of 35 FDCs declared as new drugs
CDSCO asks States and UTs to act upon list of 35 FDCs declared as new drugs: Gireesh Babu, New Delhi Wednesday, April 16, 2025, 08:00 Hrs [IST] The Drugs Controller General of Ind ...